🇺🇸·20h agoResearch
NCT06719362: A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Study type: INTERVENTIONAL. Phase: PHASE1.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- July 23, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE1.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
Women's College Hospital/3h ago
WCH researcher awarded Canadian Cancer Society Emerging Scholar Research Grant
University of Minnesota/4h ago
The truth about your 30s
University of Minnesota/4h ago
Burcum: Smoke-filled summers cannot become the norm
University of Minnesota/4h ago